BIND Therapeutics

📍 Cambridge, United States🗓 Founded 2006👥 4 employees💰 Last funded 2007
Biotechnology🌐 bindtherapeutics.com
Website LinkedIn
BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016. BIND’s product candidates were based on proprietary polymeric nanoparticles called ACCURINS®, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS®, which continue to be developed with Pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in BIND Therapeutics?
BIND Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did BIND Therapeutics last raise funding?
The most recent investment in BIND Therapeutics recorded on gritt.io was in 2007.
When was BIND Therapeutics founded?
BIND Therapeutics was founded in 2006.
What industry is BIND Therapeutics in?
BIND Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BIND Therapeutics based?
BIND Therapeutics is headquartered in Cambridge, United States.